Peptides for Sexual Health

Most treatments for sexual function work on plumbing. PDE5 inhibitors such as Viagra and Cialis relax blood vessels so more blood reaches the genitals; they do nothing for the wanting. PT-141, the peptide bremelanotide, works one level up. It activates melanocortin receptors in the brain, particularly MC4R, a pathway involved in arousal and appetite, so its effect starts in the central nervous system rather than in the vasculature.

That is what separates it from the rest of the field. Among peptides for sexual health, PT-141 is the one studied for low libido, the problem PDE5 inhibitors leave untouched, and it may support desire in people whose circulation is already fine. Results vary, and it does not replace looking for a hormonal, medication or relationship cause. The full comparison is in PT-141 vs Viagra.

Precision matters here. Bremelanotide is FDA-approved under the brand name Vyleesi, since June 2019, for one indication: acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. That is the whole approval. It does not extend to men, to postmenopausal women, or to low desire with an identifiable cause such as a medication.

Use outside that indication is off-label. Off-label prescribing is legal and common: a licensed provider can prescribe an approved molecule for a situation the label does not cover when their clinical judgment supports it, and that is how most men receive this peptide for sexual health. Two facts belong alongside that. Compounded PT-141 is not itself an FDA-approved product, and the strongest evidence, the Phase 3 RECONNECT trials, comes from premenopausal women; the evidence in men comes from smaller, earlier trials. More in Is PT-141 FDA Approved? and Is PT-141 Legal in 2026?.

Each dose raises blood pressure for a few hours, typically by about 6 mmHg systolic and 3 mmHg diastolic, peaking two to four hours after the injection. That rules PT-141 out for anyone with uncontrolled hypertension or known cardiovascular disease, and it is why the label limits use to one dose in 24 hours and no more than eight a month.

The common side effects are nausea (about 40% in trials, usually mild and easing with repeated use), flushing, headache and injection-site reactions. Focal darkening of the skin or gums is uncommon and tied to frequent dosing. Pregnancy and breastfeeding are hard stops. The right candidate is an adult with low desire that has no clear medical cause, normal blood pressure, and a provider watching both. PT-141 is a compounded medication and requires a valid prescription; results vary. The full numbers are in PT-141 Side Effects.

Starting peptides for sexual health at PeRx takes three steps and no office visit.

First, take the 60-second assessment. Answer questions about your health, blood pressure and medications, choose PT-141 and save a card; you are not charged yet.

Second, a licensed US provider reviews your file. If they approve, they write the prescription and set the dose, and only then is your card charged.

Third, it ships ready to use, with syringes, alcohol swabs and a step-by-step guide.

Take the 60-second assessment, or talk to us first.